First IL-17 Inhibitor Approved in Europe for HS Patients
The European Commission has approved the first interleukin-17A inhibitor for treating hidradenitis suppurativa.
United States Drug Administration European Union Hidradenitis Suppurativa Foundation European Commission Hidradenitis Suppurativa
Source: medscape.com